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CASE REPORT 
ALUMINIUM PHOSPHIDE POISONING: A CASE REPORT 
Shela Akbar Ali Hirani, Arshalooz Rahman* 
Aga Khan University School of Nursing, *Aga Khan University Hospital, Karachi, Pakistan 
This paper reports the case of a family in which three children were presented at Emergency Room 
(ER) with poisoning after the use of a pesticide at home. Initially, the cases were managed as 
routine cases of organophosphorus poisoning; however, the death of two children made the health 
team members realise that the poison’s effects were delayed and devastating. Later, the compound 
was identified as Aluminium Phosphide (ALP), and the life of the last surviving child in the 
family was saved. 
CASE REPORT 
Three young children of ages 8, 5, and 3 years were 
brought to the ER of a private tertiary care setting in 
Karachi, Pakistan. These children were admitted with 
complaints of diarrhoea, vomiting, and drowsiness. On 
admission, it was notified by the parents that the night 
before they had used an insecticide (25 tablets) to kill 
bed bugs in their children’s room. The insecticide was 
bought at the cost of Rs. 400/- ($5) from a door to door 
vender who sold these tablets in a closed jar by 
publicising them as bugs killing tablets. The next 
morning the parents noticed that all their three children 
were drowsy and were experiencing breathing problems 
so they rushed to the ER. The condition of the eldest 
child (8 year old girl) was very serious and she expired 
on her way to the hospital. Keeping in view the history 
and the children’s condition, the 3 year old child (male) 
was admitted in the Intensive Care Unit, whereas, the 5 
year old child (male) was admitted in the Paediatric 
Unit. The health team assumed that the inhaled 
poisoning was because of an organophosphorus 
compound utilised to kill bed bugs, so both these 
children were managed accordingly. After two days of 
treatment, the youngest child (3 year old) revealed 
improvement in his haemodynamics so he was 
discharged from the hospital. However, after 10 hours of 
his discharge from hospital the child expired at home. 
This unexpected event made the paediatric health team 
members realise that the poison may not have been an 
organophosphorus poison, as this poison does not have 
delayed effects.  
After this event, the health team members re-
examined the lastly surviving child (5 year old) both 
clinically and diagnostically. On the third day of 
hospitalization, though this child appeared clinically 
stable, his clinical examination revealed delayed 
capillary refill of 4 seconds. Moreover, his Echo 
revealed Ejection Fraction (EF) of less than 50%. After 
these findings, the child was shifted to the Cardiac Step-
down Unit, where Dopamine infusion was started and 
the child was closely monitored for his haemodynamic 
status. As the nature of poison was unknown, so the 
child’s parents were asked to bring the specimen for 
further investigation. It was shocking to observe that the 
compound was not a branded insecticide as it was 
unlabeled. The compound seemed to be a commercially 
prepared tablet and it released a strong garlic odour. 
Further analysis of the compound by the Pakistan 
Council of Scientific and Industrial Research (PCSIR) 
confirmed that it was Aluminium Phosphide. On 
knowing the type of poison and its cardiopulmonary 
toxicity, the child was managed for 2 more days with 
Methylprednisolone, Dobutamine infusion, Oxygen 
administration, and Ipratropium Nebulisation at the 
Paediatric Cardiac Step-down Unit. After 48 hours of 
therapy, Echocardiography was repeated. This showed 
an improvement in EF to 60%. Finally, the child was 
saved and after two more days of close observation, the 
child was discharged from hospital and followed in the 
consulting clinic. Currently the child is fine and the 
family is going through grieving process.  
DISCUSSION 
Aluminium Phosphide (ALP) pills produces a lethal 
Phosphine gas when it comes in contact with 
Hydrochloric Acid or water in the stomach. Phosphine 
is an extremely toxic colourless gas that releases a fishy 
or garlic-like odour.1 It is used for the fumigation of 
stored grains and the elimination of rodents in 
agriculture. Due to the poisonous nature of the 
compound it is not commonly available; however, it is 
often sold in the black markets. In the past, ALP has 
been used by Indian villagers as a way of committing 
suicide. No specific antidote has been identified as yet 
for ALP. 
The ingestion or inhalation of ALP has 
multisystem manifestations as it affects multiple 
systems, including gastrointestinal, respiratory, 
cardiovascular, musculoskeletal, central nervous system, 
and urinary system.1–3 Intentional or unintentional 
exposure to this compound can result in the victim 
having nausea, vomiting, abdominal pain, diarrhoea, 
thirst, arrhythmia, sino-atrial block, chest tightness, 
decreased EF on echocardiography, dyspnoea, 
pulmonary oedema, muscle pain, fatigue, chills, stupor, 
syncope, vertigo, fatigue, parasthesia, electrolyte 
imbalance, burning sternal pain, and renal and liver 
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damage.1–3 Cardiac toxicity in the affected individuals 
can manifest as cardiac failure and pulmonary oedema 
due to poor EF. Popp et al1 suggested that death may 
occur after a 30 minute exposure to 290 to 600 ppm, and 
serious effects may develop after exposure to 7 ppm for 
several hours.  As the compound is reported to hold 
lethal and delayed effects, therefore, an observational 
period of 72 hours is recommended to enable 
identification and management of pulmonary oedema in 
the victims.1,3 
From this case, the Paediatric Health Team 
members learnt that rather than relying on the purpose 
for which the chemical in question is used, knowing the 
composition of the poison is important to effectively 
manage paediatric patients admitted with poisoning. It 
was also realised that the health care professionals at the 
ER have the vital responsibility of taking the lead in 
knowing the chemical composition of the poison. A few 
more important lessons learnt from the situation were 
that regardless of the route of poisoning, parents should 
be asked to bring the specimen to the hospital setting. 
Also, the sample of unknown poisons should be sent for 
analysis to initiate effective and timely management of 
the cases. It is recommended that cases of poisoning 
should be taken seriously.  
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